|Publication number||US5826586 A|
|Application number||US 08/787,656|
|Publication date||Oct 27, 1998|
|Filing date||Jan 21, 1997|
|Priority date||Mar 17, 1995|
|Also published as||WO1996029030A1|
|Publication number||08787656, 787656, US 5826586 A, US 5826586A, US-A-5826586, US5826586 A, US5826586A|
|Inventors||Ajit K. Mishra, James A. Davidson, Mark A. Hamby|
|Original Assignee||Smith & Nephew, Inc.|
|Export Citation||BiBTeX, EndNote, RefMan|
|Patent Citations (13), Referenced by (68), Classifications (35), Legal Events (3)|
|External Links: USPTO, USPTO Assignment, Espacenet|
This application is a Continuation of application Ser. No. 08/475,893, filed Jun. 7, 1995, now abandoned which is a Division of application Ser. No. 08/405,898, filed Mar. 17, 1995, now abandoned.
1. Field of the Invention
The invention relates to medical implants, of all kinds, with roughened surfaces that promote cell, bone or tissue adhesion as well as the adhesion of bone cement, sometimes used to affix certain implants in place in the body. Further, the roughened surface implants of the invention are free of particulates, such as commonly arise from the blasting of implant surfaces with particulates to produce a desired surface finish.
2. Description of the Related Art
In the final stages of the preparation of medical implants, the implants are sometimes blasted with a solid medium, such as alumina, silica (glass), or silicon carbide, to roughen the surfaces. This roughening process is designed to enhance the attachment of bone, cell, tissue, or bone cement, depending upon the implant application.
Roughened surfaces may advantageously be applied to a variety of medical implants, including orthopedic implants, dental implants, cardiovascular implants, and the like. For orthopedic and dental implants, the rough surface facilitates interlocking of the implant with bone, tissue or bone cement. This tends to minimize micromotion, a phenomenon that results in loosening of the implant. Roughened surfaces on cardiovascular implants promote desirable cell attachment which has been linked with a reduction in thrombus response.
Blasting and shotpeening implants with solid media also introduce residual compressive stresses on the surface of the implants, thereby improving the fatigue strength of the device. To the extent that the surfaces can also be roughened by these treatments, fatigue strength is reduced. Thus, fatigue strength increases with greater residual surface compressive stresses and decreases with increase in surface roughness.
Regardless of the rationale for blasting implant surfaces with particulate solid media, the commonly used blasting process can result in contamination of the implant surface with fragments of the particulates. Typically, the blasting medium is carried by compressed air and is harder than the implant so that fragments of the blasting medium become embedded in or attached to the surface of the implant. Unless this residual debris is removed, it can be released into the body following implantation and cause adverse cell and tissue reactions. Even when the blasting medium is of a biocompatible material, adverse cell and tissue reactions have been observed in the presence of particulate debris. This is known as "particulate disease" and has been observed as being caused by ingestion of these particulates by macrophages which subsequently exhibit a foreign body response and release certain enzymes that cause lysis or death of bone cells. This in turn can lead to loosening of the implant and failure of the surgery. Particulate debris may also potentially migrate into spaces between articulating surfaces of a total hip or knee joint prosthesis thereby causing accelerated three-body abrasive wear. This abrasion process can also increase the generation of polymer or metal debris from the joint prosthesis and further accelerate adverse cell and tissue response. Not only does this tend to reduce the useful life of the implant, which is abraded away, but it also results in inflammation of joints and particulate disease.
There is therefore a perceived need for implants with roughened surfaces that will enhance the attachment of cells, bone, tissue or bone cement, without introducing particulate debris into the body. There is also a need for efficient methods for producing such medical implants.
While the prior art describes surface treatment processes for orthopedic implant devices, none of the art describes implants, or methods of producing implants, meeting these requirements. For example, U.S. Pat. No. 5,057,108 relates to a surface treatment process for stainless steel orthopedic implant devices. In this process, the stainless steel implant is first blasted with stainless steel shot to cold work the surface and introduce residual compressive stresses. The steel shot blasting treatment is then followed by blasting with smaller glass beads, represented as improving the fatigue properties of the surface by cold working those areas not covered by the larger steel shot. It is also represented that glass bead blasting cleans the surface of any residual steel shot that may have transferred to the implant surface. After these two steps, the surface is electropolished and passivated by immersion in nitric acid solution. However, even if the glass beads remove stainless steel contamination, the implant surface may then contain imbedded or loosely attached debris from the glass beading process. Electropolishing or passivation would not remove this cross-contamination particulate debris which would ultimately be released into the body of a patient potentially causing adverse cell reactions.
Similarly, U.S. Pat. No. 5,251,468 describes a method of blasting the surfaces of orthopedic implants with media including calcium phosphate ceramics, phosphate glass compositions, bioabsorbable glass, partially bioabsorbable glass, bioabsorbable ceramics, and partially bioabsorbable ceramics. The purpose of the blasting is to enhance the fatigue and corrosion properties of the implant and to remove residual carbon from porous surfaces of an implant. While it is represented that, because the particles are made of bioactive material they are not a cause for concern when remaining as a residue on the porous surface, it is nevertheless well known that particulate disease has been observed regardless of the nature of the debris. Thus, even the supposedly harmless bioactive blasting materials of this patent can cause particulate disease or accelerated three-body abrasive wear of total joint implants.
U.S. Pat. No. 5,236,459 describes a method in which a high pressure liquid jet is used to form cone shaped cavities in an implant on spacings to provide for intercommunication between the respective cavities. However, in order for these apertures to communicate "below the surface of the implant," significant amounts of material need to be removed and deep cavities formed. This would cause significant reduction in the fatigue strength of the implant.
U.S. Pat. No. 5,258,098 describes a chemical milling process to create an attachment surface for increasing adhesion between two objects or materials. However, the chemical etchants which are used for this purpose are strong acids which are hazardous to work with and create environmental concerns at the time of disposal after use. Further, if any of these acids remain on the implant when it is implanted, they can cause damage to the adjacent bone and tissue.
U.S. Pat. No. 5,226,260 describes a method which includes the step of eroding elastomer from a medical electronic lead using particulate abrasive. However, the patent states that the particulate should be such as to avoid scratching of the embedded metal. The patent does not address how to roughen the surface of metallic and other implants for enhanced bone or bone cement attachment.
International patent application WO 94/16836 is directed toward a method of cleaning roughened or porous-coated medical implant surfaces that contain loosely-adherent debris and particles. The disclosed method involves blasting the surface of the implant with biocompatible particulate solids in a manner which dislodges the debris and particles. This method, however, only cleans the surface and does not itself roughen the surface or produce residual compressive stresses in the surface.
The invention is directed to a method of forming medical implants, of all kinds, with roughened surfaces for enhanced cell and bone cement attachment, and implants with such surfaces. The implant surfaces may have residual compressive stresses and are free of particulate debris, thereby reducing or eliminating the potential for particulate disease and curtailing the potential for accelerated three-body abrasive wear caused by particulate debris.
The preferred methods for producing medical implants according to the invention include subjecting surfaces of the medical implant to a high pressure jet of a biocompatible liquid. The impact pressure of the solvent on the implant surface should be sufficient to remove machining debris and also roughen the surface for bone, cell, tissue or bone cement adhesion. It may also introduce residual compressive stresses into the surface to enhance fatigue strength.
In alternative embodiments of the preferred method, the biocompatible liquid may include a biocompatible, solid particulate medium, such as non-toxic soluble salts, non-toxic particulate solids that deliquesce, sublimate or vaporize, but that are sufficiently hard to provide an effective impact on the implant surface to create a roughened surface for bone, tissue, cells or bone cement adhesion.
After the implant surface is blasted with the biocompatible liquid containing biocompatible particulate solids described above, the implant may optionally be subjected to ultrasonic cleaning or flushing with a biocompatible liquid medium to remove or dissolve any blasting residue.
Finally, the roughened implant surface may be further treated to provide a chemically passive surface. Such passivation techniques include dipping in solutions of nitric acid, or passivating by immersion in solutions of non-aggressive oxyanions, as detailed in U.S. Pat. No. 5,211,663, which is hereby fully incorporated by reference. The process parameters used during the blasting process may be adjusted depending upon whether roughening the surface for enhanced cement, bone, tissue or cell attachment is the primary objective, or improving the fatigue strength by introducing residual compressive stresses is the primary objective. If roughening the surface is the primary objective, more aggressive blasting methods, e.g., higher blasting pressure, greater duration of blasting and/or smaller blasting nozzle distance, may be employed. If improvement in fatigue strength is the primary objective, roughening of the surface should be minimized by judicious selection of the operating variables since increased surface roughness causes reduction in fatigue strength. If solid blasting media are being used, this may involve using more spherical media and/or denser media which would resist fragmentation and minimize roughening of the substrate.
FIG. 1 is a photomicrograph of a surface of cobalt-chrome-molybdenum alloy disk (C-7) at 50 times magnification after being hydroblasted with water only.
FIG. 2 is a photomicrograph of the surface of cobalt-chrome-molybdenum alloy femoral knee component at 50 times magnification, after blasting with alumina grit.
FIG. 3 is a photomicrograph at 200 times magnification of a water jet blasted cobalt-chrome-molybdenum alloy disc (C-7).
FIG. 4 is a photomicrograph at 200 times magnification of an alumina grit blasted cobalt-chrome-molybdenum knee femoral component.
FIG. 5 is a photomicrograph at 50 times magnification of the surface of a water jet blasted Ti-6Al-4V alloy disc (T-4).
FIG. 6 is a photomicrograph at 50 times magnification of an alumina grit blasted Ti-6Al-4V knee tibial component.
FIG. 7 is a photomicrograph at 200 times magnification of the surface of a water jet blasted Ti-6Al-4V alloy disc (T-4).
FIG. 8 is a photomicrograph at 200 times magnification of an alumina grit blasted Ti-6Al-4V knee tibial component.
FIG. 9 is a photomicrograph at 50 times magnification of the surface of a water jet blasted aluminum disc (A-7).
FIG. 10 is a photomicrograph at 50 times magnification of the surface of an alumina grit blasted aluminum instrument handle.
FIG. 11 is a photomicrograph at 200 times magnification of the surface of a water jet blasted aluminum disc (A-7).
FIG. 12 is a photomicrograph at 200 times magnification of the surface of an alumina grit blasted aluminum instrument handle.
FIG. 13 is a schematic of the equipment used for the invention blasting process.
The roughened surface implants, according to the invention, which are free of particulate debris, are preferably produced by blasting implant surfaces with biocompatible liquids at high pressures. These liquids may further contain soluble, vaporizable, or deliquescable solid particulates. The resultant surfaces are roughened for improved tissue and cell adhesion, and bone cement adhesion, as required. Also, the surfaces may contain residual compressive stresses that enhance the fatigue strength of the implant.
In a preferred embodiment of the methods for producing implants according to the invention, an implant surface is subjected to blasting with pressurized water. The pressure of the water is selected depending upon the hardness of the surface material of the medical implant. Thus, a softer metal, such as aluminum, will require a lower water pressure than a harder metal alloy, such as cobalt-chrome-molybdenum, to produce the same roughness index on the surface. For instance, in order to produce an average surface roughness (Ra) of 250 micro-inches on an aluminum implant surface, the water pressure should range from about 10,000 to about 90,000 psi, if the implant is located 0.5 inches distance from the point at which the water exits a jet tip and the traverse-rate (the speed of travel of the spray nozzle) is about 4 inches per second. To produce a cobalt-chrome-molybdenum medical implant of the same roughness, the water pressure should range from about 10,000 to about 90,000 psi, and should be located at a distance of 0.5 inches from the tip of the water jet, and the traverse-rate should be about 100 times lower at 0.04 inches per second. The lower traverse-rate permits blasting of the material for longer periods of time and this is essential due to the greater hardness of Co-Cr-Mo compared to aluminum. The same effect can also be produced by using a higher pressure instead of a lower traverse-rate. This can also be achieved by using a shorter working distance (i.e., the distance between the blasting nozzle and the implant).
Implants, according to the invention, may be produced from a wide range of metals and alloys, including such materials as titanium, cobalt, zirconium, tantalum, niobium, nickel, aluminum, and their alloys, as well as stainless steels. Implants, according to the invention, may also be produced from ceramic and plastics. Some of these metals or alloys are harder than others so that blasting parameters should be adjusted to achieve a desired Ra. Therefore, for example, the suitable pressure parameter range can be from about 3,000 psi to about 90,000 psi. The desired Ra is one such that the roughness is high enough to promote attachment of tissue, bone, cells, or bone cement, but low enough to minimize adverse effects on wear and fatigue strength.
One of the blasting parameters that may be varied, according to the invention, is the density of the liquid biocompatible blasting medium. Thus, denser liquids have higher impact on the implant surface and hence are more effective at roughening harder surfaces.
The average surface roughness (Ra) and the topography of the roughened surface, may be altered by a judicious selection of operating variables in the hydroblaster. These variables include but are not limited to the blasting pressure, duration of blasting, distance of blasting nozzle from implant surface, the number of blasting passes over a given area, the configuration of the jet-spray (e.g., fan type or orifice type). In the event that particulates are included in the blasting medium to assist in imparting residual compressive stresses to the surface and/or to roughen the surface, then further operating variables such as the size, shape and hardness of the particles used also have a significant effect on the topography of the roughened surface produced. Thus, for instance, particles of larger size and higher hardness will tend to produce greater surface roughening as well as higher residual compressive stresses. More spherical particles would tend to cause less surface roughening and higher residual compressive stresses. Denser particles, which would tend to resist fragmentation, would also have the same effect.
Blasting with either biocompatible liquids or solid particulates in a fluid carrier medium may be accomplished using many different types of spray nozzles, depending upon the type of surface desired. A 0° orifice nozzle directs a stream of the blasting medium at a small area of the workpiece. A 15° fan nozzle directs a fan-type spray of the blasting medium over a larger area of the workpiece. Other types of spray patterns can also be produced by judicious selection of the blasting nozzle. The nozzles may be rotated continuously about their own axis to convert a fan-shaped spray to a cone-shaped spray. The workpiece and/or the spray gun may be subjected to translation, revolution or rotation to ensure uniform blasting of different areas of the workpiece. The spray-gun may be moved horizontally, vertically, or both (to produce a cross-hatch pattern).
The degree and nature of surface roughening produced by the blasting process is measured by a number of parameters. The most commonly used parameter is the average surface roughness, Ra. This is a measure of the arithmetic average deviation of the roughness profile from its mean line. Thus this parameter gives equal weight to peaks as well as valleys on the surface. The reduced peak height, Rpk, is a parameter which is a measure of the number and height of the peaks on the surface. Reduced valley depth, Rvk, is a measure of the number and depth of the valleys on the surface.
The following examples are illustrative of the invention and are not intended to limit the scope of the invention as described above and claimed hereafter.
Three materials commonly used in medical implants, wrought (ASTM F 799) cobalt-chrome-molybdenum, Ti-6Al-4V, and aluminum, were selected for subjecting to blasting using various combinations of blasting media and blasting parameters. The hardness of these materials were as follows:
______________________________________Material Hardness (VHN)______________________________________Aluminum 107Ti-6Al-4V 370Cobalt-Chrome-Molybdenum (ASTM F 799) 465______________________________________ (where VHN stands for Vickers Hardness Number)
Disc specimens of each of these materials were blasted at a pressure of 10,000 psi with water as a carrier including salt particles. Other specimens were hydroblasted with water only at a pressure of 36,000 psi. The results are as shown in Table 1.
TABLE 1__________________________________________________________________________ Average Reduced Reduced Surface Peak Valley Roughness Height Depth Water Traverse Number (Ra) (Rpk) (Rvk)SpecimenSpecimen Pressure Media Rate of (micro (micro (microNumberMaterial (psi) Used (ips) passes inches) inches) inches)__________________________________________________________________________A-2 Aluminum 10000 salt ** ** 244 222 896A-3 " 10000 salt ** ** 96 92 459A-4 " 36000 none 0.1 1 816 172 1126A-5 " 36000 none 1 1 663 352 154A-6 " 36000 none 2 1 322 332 540A-7 " 36000 none 4 1 257 389 228T-2 Ti--6Al--4V 10000 salt ** ** 33 51 92T-3 " 10000 salt ** ** 71 14 42T-4 " 36000 none 0.1 1 203 274 336T-5 " 36000 none 0.25 1 193 140 380T-7 " 36000 none 0.33 1 211 143 412T-8 " 36000 none 0.4 1 105 23 437T-9 " 36000 none 1 1 43 34 31C-5 ASTM F799 36000 none 0.04 1 93 33 516Co--Cr--MoC-6 " 36000 none 0.04 2 244 178 455C-7 " 36000 none 0.04 3 233 241 525__________________________________________________________________________ The salt used here is sodium chloride. **Manual Operation, procees parameters do not apply Note: All tests used a 15° fan jet spray nozzle and a 0.5 inch working distance. All roughness measurements (Ra, Rpk, and Rvk) were performed using a profilometry trace perpendicular to the direction of travel of the blasting nozzle. The following equipment settings were used: Trace Length = 0.050 inch, Cutoff Length = 0.030 inch, Tracing Spee = 0.012 inch/sec., Phase Correction Filter Activated.
A roughened surface for enhancement of cement or bone attachment was achieved on an aluminum specimen by blasting with salt using water as the carrier medium at 10,000 psi. The roughness (Ra) of the surface was 244 micro inches. However, under the same conditions, surface roughness of the Ti-6Al-4V specimens (T-2 and T-3)were considerably lower due to the greater hardness of this material relative to aluminum. It is expected that even higher pressures or harder blasting media would be required to produce a comparable surface roughness on cobalt-chrome-molybdenum disks, which have considerably harder surfaces.
Blasting with water alone was effective to produce an average roughness (Ra) of 257 micro inches on the aluminum specimen A-7 using a spray nozzle travel speed of 4.0 inches per second. Lower traverse-rates produced even higher surface roughness values. Since increased roughness tends to cause reduction in fatigue strength, process parameters may be adjusted to insure that the surface produced is not so rough as to cause an unacceptable reduction in fatigue strength in the implant.
Blasting with water at 36,000 psi, without salt, was effective in producing a surface roughness (Ra) of 203 micro-inches on a Ti-6Al-4V specimen, T-4. The higher pressure was achievable due to the smaller nozzle useable in the absence of solid blasting media.
Even for the cobalt-chrome-molybdenum disks, which have a high hardness, (465 VHN), blasting with water produced an average roughness (Ra) of 233 micro-inches and 244 micro-inches respectively on specimens C-6 and C-7. However, to achieve this roughness, a traverse-rate of 0.04 inch per second was required, along with 2-3 passes of the spray over the surface.
The equipment used for the water-jet blasting, as well as the salt and water blasting described in Table 1, was manufactured by National Liquid Blasting, Wixom, Mo. A schematic of the equipment is shown in FIG. 13. The equipment includes: a Z-axis adjustable blasting nozzle (2); a X-axis, Y-axis, and rotational fixturing (3); a sonic insulated stainless steel blasting enclosure (4); controls for high pressure liquid supply and position, speed and traverse-rate movements for X-, Y- and Z-axes as well as rotation (5); a regulated high pressure water supply (6); an electric motor driven pump and high pressure manifold (7); and a filtered tap water inlet (8). The working distance (9), the distance between the top surface of the workpiece (1) and the nozzle tip, is typically 0.25 inches with a #5 nozzle.
Photomicrographs, at various magnifications, were taken of specimens tabulated in Table 1 for comparison with alumina grit blasted surfaces produced by prior art methods. Thus, FIGS. 1 and 3 are photomicrographs of specimen C-7 that may be compared with alumina grit blasted cobalt-chrome-molybdenum shown in FIGS. 2 and 4. Likewise, FIGS. 5 and 7 are photomicrographs of the surface of specimen T-4 for comparison with alumina grit blasted Ti-6Al-4V shown in FIGS. 6 and 8. FIGS. 9 and 11 are photomicrographs of the surface of specimen A-7 for comparison with alumina grit blasted aluminum surfaces shown in FIGS. 10 and 12. The roughness values of the alumina grit blasted devices were also measured using the same measurement parameters and are given below:
TABLE 2______________________________________ Average Reduced Reduced Roughness Peak Height Valley Depth Ra (micro Rpk (micro (Rvk)(microSpecimen Material inches) inches) inches)______________________________________Aluminum 244 252 576Ti-6Al-4V 250 231 498Cast Co--Cr--Mo 161 304 351(ASTM F 75)Cast Co--Cr--Mo 221 295 108(F 75)Cast Co--Cr--Mo 256 257 206(F 75)Cast Co--Cr--Mo 285 169 517(F 75)Wrought Co--Cr--Mo 196 356 383(ASTM F 799)______________________________________
Cylindrical rods of wrought (ASTM F 799) Co-Cr-Mo alloy were subjected to water-jet blasting with a 15° fan jet nozzle at a pressure of 36,000 psi, traverse rate of 0.05 inch/sec and a working distance of 0.375 inch, for approximately 15 passes. The rods were rotated at approximately 11 rpm to ensure uniform texturing of the surface. The roughness values of the specimens were determined by profilometry using the following equipment settings: Trace Length=0.08 inch, Cut-off Length=0.03 inch, Tracing Speed=0.012 inch/sec. The rods were subsequently potted in PMMA bone cement, the cement was allowed to set, and the force required to remove the rods from the cement was measured.
Similar Co-Cr-Mo rods were also subjected to standard alumina grit-blasting, using prior art methods, and their roughness values and cement attachment strength determined, as described above.
The results of both sets of tests are given in Table 3.
TABLE 3______________________________________ Reduced Avg. surface Reduced peak valley Cement roughness, height, depth, attachmentBlasting Ra (micro Rpk (micro- Rvk (micro- StrengthMedium inches) inches) inches) (psi)______________________________________Water-jet 166 96 205 1595Water-jet 176 130 408 1780Water-jet 191 70 365 1695Water-jet 221 156 346 2027Water-jet 227 163 342 1760Average 196 ± 27 123 ± 40 333 ± 76 1771 ± 160Alumina Grit 151 272 322 1214Alumina Grit 154 178 199 1225Alumina Grit 167 161 202 1255Alumina Grit 187 284 273 1300Alumina Grit 149 146 319 1126Average 162 ± 16 208 ± 65 263 ± 60 1224 ± 64______________________________________
As shown in the Table, water-jet blasting using the process parameters described above produced a slightly higher cement attachment strength compared to prior art alumina grit blasting. While not wishing to be bound by any theory, the inventors offer the following explanation of this phenomenon. Under certain sets of blasting conditions, the water-jet blasting process can produce smaller, more rounded peaks (smaller Rpk) and larger valleys (greater Rvk) compared to standard grit-blasting, although the overall surface roughness (Ra) may be comparable. This can potentially lead to higher cement attachment strength for water-jet blasted implants, compared to prior-art alumina grit-blasted implants.
Having described the invention above, various modifications of the techniques, procedures, material and equipment will be apparent to those in the art. It is intended that all such variations within the scope and spirit of the appended claims be embraced thereby.
|Cited Patent||Filing date||Publication date||Applicant||Title|
|US4617064 *||Jul 31, 1984||Oct 14, 1986||Cryoblast, Inc.||Cleaning method and apparatus|
|US5057108 *||Jan 12, 1990||Oct 15, 1991||Zimmer, Inc.||Method of surface finishing orthopedic implant devices|
|US5147466 *||Sep 27, 1990||Sep 15, 1992||Mitsubishi Denki Kabushiki Kaisha||Method of cleaning a surface by blasting the fine frozen particles against the surface|
|US5226260 *||Jan 9, 1992||Jul 13, 1993||Ventritex, Inc.||Method for manufacturing implantable cardiac defibrillation leads utilizing a material removal process|
|US5236459 *||Aug 31, 1992||Aug 17, 1993||Sulzer Brothers Limited||Bone implant and method of making same|
|US5251468 *||Dec 14, 1992||Oct 12, 1993||Zimmer, Inc.||Method of surface finishing orthopaedic implant devices using a bioactive blasting medium|
|US5258098 *||Sep 6, 1991||Nov 2, 1993||Cycam, Inc.||Method of production of a surface adapted to promote adhesion|
|US5307594 *||Dec 14, 1992||May 3, 1994||Zimmer, Inc.||Method for forming textured surfaces on an orthopaedic implant|
|US5317841 *||Aug 28, 1992||Jun 7, 1994||Whitemetal, Inc.||Method for removal of surface contaminants from metal substrates|
|US5344494 *||Jan 21, 1993||Sep 6, 1994||Smith & Nephew Richards, Inc.||Method for cleaning porous and roughened surfaces on medical implants|
|US5607480 *||Nov 10, 1993||Mar 4, 1997||Implant Innovations, Inc.||Surgically implantable prosthetic devices|
|EP0602712A2 *||Dec 6, 1993||Jun 22, 1994||Bristol-Myers Squibb Company||Method of surface finishing orthopaedic implant devices using a bioactive blasting medium|
|WO1994016836A1 *||Jan 21, 1994||Aug 4, 1994||Smith & Nephew Richards Inc||Cleaning porous and roughened surfaces on medical implants|
|Citing Patent||Filing date||Publication date||Applicant||Title|
|US6599322||Oct 12, 2001||Jul 29, 2003||Tecomet, Inc.||Method for producing undercut micro recesses in a surface, a surgical implant made thereby, and method for fixing an implant to bone|
|US6620332||Dec 12, 2001||Sep 16, 2003||Tecomet, Inc.||Method for making a mesh-and-plate surgical implant|
|US6764505||Apr 12, 2001||Jul 20, 2004||Advanced Cardiovascular Systems, Inc.||Variable surface area stent|
|US6797007 *||Mar 25, 1999||Sep 28, 2004||Ceramtec Ag Innovative Ceramic Engineering||Press fit connection between prosthesis components of joint prostheses|
|US7018418||Jul 24, 2002||Mar 28, 2006||Tecomet, Inc.||Textured surface having undercut micro recesses in a surface|
|US7144427||Dec 5, 2002||Dec 5, 2006||Depuy Products, Inc.||Apparatus and method for advancing synovial fluid in a prosthetic joint|
|US7169173||Sep 22, 2003||Jan 30, 2007||Advanced Cardiovascular Systems, Inc.||Composite stent with regioselective material and a method of forming the same|
|US7169178||Nov 12, 2002||Jan 30, 2007||Advanced Cardiovascular Systems, Inc.||Stent with drug coating|
|US7501073||Feb 2, 2004||Mar 10, 2009||Depuy Products, Inc.||Methods for producing metallic implants having roughened surfaces|
|US7666223||Nov 8, 2006||Feb 23, 2010||Advanced Cardiovascular Systems, Inc.||Stent with drug coating|
|US7666229||Nov 12, 2004||Feb 23, 2010||Amedica Corporation||Ceramic-ceramic articulation surface implants|
|US7674493||Apr 6, 2004||Mar 9, 2010||Advanced Cardiovascular Systems, Inc.||Method of making a variable surface area stent|
|US7695521||Aug 12, 2005||Apr 13, 2010||Amedica Corporation||Hip prosthesis with monoblock ceramic acetabular cup|
|US7758646||Jun 9, 2005||Jul 20, 2010||Amedica Corporation||Total disc implant|
|US7771481||Sep 19, 2007||Aug 10, 2010||Amedica Corporation||Total disc implant|
|US7776085||Sep 8, 2005||Aug 17, 2010||Amedica Corporation||Knee prosthesis with ceramic tibial component|
|US7780738||Dec 21, 2004||Aug 24, 2010||Amedica Corporation||Polymer-ceramic articulation|
|US7820229||Nov 8, 2006||Oct 26, 2010||Advanced Cardiovascular Systems, Inc.||Method of coating a stent|
|US7824440||Oct 12, 2006||Nov 2, 2010||Advanced Cardiovascular Systems, Inc.||Stent with drug coating|
|US7824441||Nov 8, 2006||Nov 2, 2010||Advanced Cardiovascular Systems, Inc.||Stent with drug coating|
|US7850862||Feb 1, 2006||Dec 14, 2010||Tecomet Inc.||Textured surface having undercut micro recesses in a surface|
|US7862495||May 31, 2001||Jan 4, 2011||Advanced Cardiovascular Systems, Inc.||Radiation or drug delivery source with activity gradient to minimize edge effects|
|US7867061 *||Sep 20, 2006||Jan 11, 2011||Mentor Worldwide Llc||Texturizing surfaces|
|US7867547||Dec 19, 2005||Jan 11, 2011||Advanced Cardiovascular Systems, Inc.||Selectively coating luminal surfaces of stents|
|US7901462 *||Jun 23, 2005||Mar 8, 2011||Depuy Products, Inc.||Implants with textured surface and methods for producing the same|
|US8003156||May 4, 2006||Aug 23, 2011||Advanced Cardiovascular Systems, Inc.||Rotatable support elements for stents|
|US8017237||Jun 23, 2006||Sep 13, 2011||Abbott Cardiovascular Systems, Inc.||Nanoshells on polymers|
|US8025916||Dec 18, 2006||Sep 27, 2011||Abbott Cardiovascular Systems Inc.||Methods for forming a composite stent with regioselective material|
|US8048441||Jun 25, 2007||Nov 1, 2011||Abbott Cardiovascular Systems, Inc.||Nanobead releasing medical devices|
|US8048448||Jun 15, 2006||Nov 1, 2011||Abbott Cardiovascular Systems Inc.||Nanoshells for drug delivery|
|US8119184||Jan 15, 2010||Feb 21, 2012||Advanced Cardiovascular Systems, Inc.||Method of making a variable surface area stent|
|US8123812||Aug 27, 2009||Feb 28, 2012||Amedica Corporation||Ceramic-ceramic articulation surface implants|
|US8197879||Jan 16, 2007||Jun 12, 2012||Advanced Cardiovascular Systems, Inc.||Method for selectively coating surfaces of a stent|
|US8241361||Sep 19, 2008||Aug 14, 2012||Deru Gmbh||Endoprosthesis component|
|US8252058||Feb 16, 2006||Aug 28, 2012||Amedica Corporation||Spinal implant with elliptical articulatory interface|
|US8293367||Jul 15, 2011||Oct 23, 2012||Advanced Cardiovascular Systems, Inc.||Nanoshells on polymers|
|US8419507 *||Nov 30, 2010||Apr 16, 2013||Mentor Worldwide Llc||Texturizing surfaces|
|US8465789||Jul 18, 2011||Jun 18, 2013||Advanced Cardiovascular Systems, Inc.||Rotatable support elements for stents|
|US8592036||Sep 20, 2012||Nov 26, 2013||Abbott Cardiovascular Systems Inc.||Nanoshells on polymers|
|US8596215||Jul 18, 2011||Dec 3, 2013||Advanced Cardiovascular Systems, Inc.||Rotatable support elements for stents|
|US8603530||Jun 14, 2006||Dec 10, 2013||Abbott Cardiovascular Systems Inc.||Nanoshell therapy|
|US8637110||Jul 18, 2011||Jan 28, 2014||Advanced Cardiovascular Systems, Inc.||Rotatable support elements for stents|
|US8696759||Apr 15, 2009||Apr 15, 2014||DePuy Synthes Products, LLC||Methods and devices for implants with calcium phosphate|
|US8741379||Jul 18, 2011||Jun 3, 2014||Advanced Cardiovascular Systems, Inc.||Rotatable support elements for stents|
|US8808342||Apr 23, 2013||Aug 19, 2014||Abbott Cardiovascular Systems Inc.||Nanoshell therapy|
|US8961584||Dec 18, 2006||Feb 24, 2015||Abbott Cardiovascular Systems Inc.||Composite stent with regioselective material|
|US20030178387 *||Mar 14, 2003||Sep 25, 2003||Mark Amrich||Method for making a mesh-and-plate surgical implant|
|US20040016651 *||Mar 20, 2003||Jan 29, 2004||Markus Windler||Method for the manufacture of an implant, a method for the decontamination of a surface treated with blasting particles and a medical implant|
|US20040111162 *||Dec 5, 2002||Jun 10, 2004||Southworth Carleton B.||Apparatus and method for advancing synovial fluid in a prosthetic joint|
|US20040167632 *||Feb 24, 2003||Aug 26, 2004||Depuy Products, Inc.||Metallic implants having roughened surfaces and methods for producing the same|
|US20040167633 *||Feb 2, 2004||Aug 26, 2004||Depuy Products, Inc.||Metallic implants having roughened surfaces and methods for producing the same|
|US20040199261 *||Feb 20, 2004||Oct 7, 2004||Benoist Girard Sas||Surface treatment for a metal prosthesis|
|US20050031698 *||Aug 14, 2002||Feb 10, 2005||Shinichi Sotome||Materials sustainedly releasing drug in vivo|
|US20050049706 *||Sep 14, 2004||Mar 3, 2005||Amedica Corporation, A Delaware Corporation||Radiolucent spinal fusion cage|
|US20060020266 *||Jan 27, 2004||Jan 26, 2006||Cooper John J||Bioabsorbable implant|
|US20060293758 *||Jun 23, 2005||Dec 28, 2006||Depuy Products, Inc.||Implants with textured surface and methods for producing the same|
|US20080071371 *||Sep 20, 2006||Mar 20, 2008||Robert Elshout||Texturizing surfaces|
|US20090082849 *||Sep 19, 2008||Mar 26, 2009||Deru Gmbh||Endoprosthesis component|
|US20110070356 *||Nov 30, 2010||Mar 24, 2011||Mentor Worldwide Llc||Texturizing Surfaces|
|CN102006838B||Aug 7, 2008||Jul 23, 2014||Deru股份公司||Endoprosthesis component|
|EP1386591A1 *||Jul 24, 2002||Feb 4, 2004||Centerpulse Orthopedics Ltd.||Method for manufacturing an implant, method for decontamination of a particle-blasted surface, and medical implant|
|EP1583669A2 *||Jan 9, 2004||Oct 12, 2005||Medsource Technologies Pittsburgh, Inc.||Improved surface for use on implantable device|
|EP1901858A2 *||Jun 16, 2006||Mar 26, 2008||American Sterilizer Company||Method for cleaning a lumen|
|EP1901858A4 *||Jun 16, 2006||Nov 4, 2009||American Sterilizer Co||Method for cleaning a lumen|
|EP1902688A1 *||Sep 17, 2007||Mar 26, 2008||Mentor Corporation||Texturizing surfaces|
|WO2002083039A1 *||Apr 12, 2002||Oct 24, 2002||Advanced Cardiovascular System||Variable surface area stent|
|WO2009036845A2 *||Aug 7, 2008||Mar 26, 2009||Deru Gmbh||Endoprosthesis component|
|WO2009036845A3 *||Aug 7, 2008||Jul 16, 2009||Deru Gmbh||Endoprosthesis component|
|U.S. Classification||128/898, 623/23.5, 134/7, 623/901|
|International Classification||A61F2/30, B08B3/02, B24C1/00, B08B7/02, A61F2/00, A61F2/38|
|Cooperative Classification||Y10S623/901, A61F2002/30906, A61F2250/0025, A61F2310/00089, B08B7/02, A61F2310/00047, A61F2/3094, A61F2/389, B08B3/02, A61F2310/00179, A61F2/30767, A61F2310/00071, B24C1/003, A61F2002/30321, A61F2310/00029, A61F2310/00023, A61F2310/00131, A61F2002/30976, A61F2/3859, A61F2310/00095, A61F2310/00017|
|European Classification||B08B3/02, A61F2/30L, B08B7/02, B24C1/00B|
|May 14, 2002||REMI||Maintenance fee reminder mailed|
|Oct 28, 2002||LAPS||Lapse for failure to pay maintenance fees|
|Dec 24, 2002||FP||Expired due to failure to pay maintenance fee|
Effective date: 20021027